Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Intercept Pharmaceuticals, Inc. (ICPT)

Pharmaceutical Preparations

https://www.interceptpharma.com

Intercept Pharmaceuticals Inc is a biotech company focused on developing and commercializing novel therapeutics to treat progressive non-viral liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being developed for a variety of chronic liver diseases, including nonalcoholic steatohepatitis, or NASH.

305 MADISON AVENUE
MORRISTOWN, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/11/2012

Market Cap

794,694,000

Shares Outstanding

41,810,000

Weighted SO

41,825,966

Total Employees

N/A

Upcoming Earnings

03/07/2024

Similar Tickers

VKTX --.--%

TERN --.--%

AKRO --.--%

RETA --.--%

MDGL --.--%

TGTX --.--%

HEPA --.--%

PTCT --.--%

KRYS --.--%

Beta

0.8840

Last Div

0.0000

Range

8.82-21.86

Chg

0.0400

Avg Vol

2054565

Mkt Cap

794694000

Exch

NASDAQ

Country

US

Phone

646 747 1000

DCF Diff

0.8808

DCF

17.5192

Div Yield

0.0000

P/S

2.5015

EV Multiple

-21.9741

P/FV

11.0522

Div Yield %

0.0000

P/E

-13.5480

PEG

-0.0774

Payout

0.0000

Current Ratio

4.2209

Quick Ratio

3.9099

Cash Ratio

1.1309

DSO

37.3164

DIO

1527.4645

Op Cycle

1564.7809

DPO

5920.1501

CCC

-4355.3692

Gross Margin

0.9980

Op Margin

-0.1960

Pretax Margin

-0.1826

Net Margin

-0.1845

Eff Tax Rate

-0.1486

ROA

-0.1491

ROE

-0.7824

ROCE

-0.2060

NI/EBT

1.0103

EBT/EBIT

0.9315

EBIT/Rev

-0.1960

Debt Ratio

0.5694

D/E

3.1158

LT Debt/Cap

0.7570

Total Debt/Cap

0.7570

Int Coverage

-6.2429

CF/Debt

-0.2815

Equity Multi

5.4724

Rec Turnover

9.7812

Pay Turnover

0.0617

Inv Turnover

0.2390

FA Turnover

386.4769

Asset Turnover

0.8080

OCF/Share

-1.5079

FCF/Share

-1.5035

Cash/Share

7.7219

OCF/Sales

-0.1984

FCF/OCF

0.9970

CF Coverage

-0.2815

ST Coverage

0.0000

CapEx Coverage

-338.8118

Div&CapEx Cov

-338.8118

P/BV

11.0522

P/B

11.0522

P/S

2.5015

P/E

-13.5480

P/FCF

-12.6477

P/OCF

-12.6001

P/CF

-12.6001

PEG

-0.0774

P/S

2.5015

EV Multiple

-21.9741

P/FV

11.0522

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 08, 09:13 Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.

Revenue Product Segmentation